Cardiovascular Systems Inc. (NASDAQ:CSII)’s share price reached a new 52-week high during trading on Wednesday . The company traded as high as $24.85 and last traded at $24.58, with a volume of 138,774 shares traded. The stock had previously closed at $24.34.

A number of equities analysts have commented on CSII shares. Needham & Company LLC lifted their price objective on shares of Cardiovascular Systems from $16.00 to $20.00 and gave the stock a “buy” rating in a report on Thursday, May 5th. Leerink Swann reaffirmed a “market perform” rating and issued a $15.00 price objective (up previously from $13.00) on shares of Cardiovascular Systems in a report on Saturday, May 7th. Zacks Investment Research raised shares of Cardiovascular Systems from a “hold” rating to a “buy” rating and set a $21.00 price objective for the company in a report on Monday, July 4th. Finally, Bank of America Corp. raised shares of Cardiovascular Systems from an “underperform” rating to a “neutral” rating in a report on Thursday, August 4th. Two research analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. Cardiovascular Systems presently has a consensus rating of “Buy” and a consensus target price of $23.71.

The stock’s market capitalization is $800.91 million. The stock’s 50-day moving average is $20.37 and its 200 day moving average is $15.17.

Cardiovascular Systems (NASDAQ:CSII) last announced its earnings results on Wednesday, August 3rd. The medical device company reported ($0.15) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.20) by $0.05. The company had revenue of $48.50 million for the quarter, compared to the consensus estimate of $46.01 million. During the same period in the previous year, the company earned ($0.27) EPS. The firm’s revenue for the quarter was up .0% compared to the same quarter last year. On average, analysts expect that Cardiovascular Systems Inc. will post ($0.62) EPS for the current year.

In other news, SVP Paul A. Koehn sold 4,000 shares of the company’s stock in a transaction that occurred on Wednesday, August 17th. The stock was sold at an average price of $22.17, for a total transaction of $88,680.00. Following the completion of the transaction, the senior vice president now directly owns 102,652 shares in the company, valued at $2,275,794.84. The sale was disclosed in a filing with the SEC, which can be accessed through this link.

A hedge fund recently raised its stake in Cardiovascular Systems stock. Schwab Charles Investment Management Inc. raised its position in Cardiovascular Systems Inc. (NASDAQ:CSII) by 3.1% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 98,841 shares of the medical device company’s stock after buying an additional 2,932 shares during the period. Schwab Charles Investment Management Inc. owned about 0.30% of Cardiovascular Systems worth $1,495,000 at the end of the most recent reporting period.

Cardiovascular Systems, Inc is a medical technology company. The Company is engaged in treating patients suffering from peripheral and coronary arterial diseases. It has developed an orbital atherectomy technology for peripheral and coronary commercial applications. Its peripheral arterial disease systems are catheter-based platforms that treat plaque types in leg arteries both above and below the knee.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.